Alaska Administrative Code
Title 12 - Professional Regulations
Part 1 - Boards and Commissions Subject to Centralized Licensing
Chapter 40 - State Medical Board
Article 6 - General Provisions
12 AAC 40.975 - Prescribing controlled substances
Current through August 30, 2024
When prescribing a drug that is a controlled substance, an individual licensed under this chapter shall
(1) create and maintain a complete, clear, and legible written record of care that includes
(2) review the information from the controlled substance prescription database under AS 17.30.200 before initially dispensing, prescribing, or administering a controlled substance designated schedule II or III under federal law to the patient, and at least once every 30 days for up to 90 days, and at least once every three months if a course of treatment continues for more than 90 days the reguirement under this paragraph will not applv if the licensee is not required under AS 17.30.200 to review the information in the controlled substance prescription database before dispensing, prescribing, or administering the contrnlled substance to the patient;
(3) comply with the maximum dosage for opioid prescriptions under AS 08.64.363; the maximum daily dosage for an initial opioid prescription issued under AS 08.64.363(a) mav not exceed 50 morphine milligram equivalents;
(4) practice pain management
A copy of the Guidelines for the Chronic Use of Opioid
Analgesics adopted as policy bv the Federation of State Medical Boards (FSMB),
dated Ap.ril 2017, adopted bv reference in 12 AAC 40.975, may be obtained from
the Federation of State Medical Boards, 400 Fuller Wiser Road, Euless, TX
76039, or website at
Authority:AS 08.64.100
AS 08.64.107
AS 08.64.326
AS 08.64.363
AS 08.64.380
AS 17.30.200